Question

Will tirzepatide be approved for the treatment of obesity by the FDA or EMA before 2025?

Resolved :Yes

8 comments8

Total Forecasters36

Community Prediction80%

Make a Prediction

50%

community: 80%

Did this actually happen?Yes

Community Baseline Score

29.9

Community Peer Score

1.3

median 80.0%mean 80.5%

Authors:

casens

Opened:

Closes:

Resolves:

Eli Lilly and Company

Semaglutide

Pharmacology

Obesity

Food and Drug Administration

Is Ozempic the modern wonder drug? All the conditions the weight loss jab can tackle — from addiction to Alzheimer’s

New York Post•Nov 12, 2024

Scientific breakthrough to prevent negative side effects of weight loss drugs like Ozempic

Independent•Nov 14, 2024

New weight loss drug decreases appetite without nausea — and can even burn calories

New York Post•Nov 14, 2024

Learn more about Metaculus NewsMatch

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%

Comments

? comments